Scarica l'app Stockscreener
32.40
0.47%
0.15
Dopo l'orario di chiusura:
32.41
0.010
+0.03%
Precedente Chiudi:
$32.25
Aprire:
$32.05
Volume 24 ore:
1.10M
Relative Volume:
0.91
Capitalizzazione di mercato:
$5.98B
Reddito:
$797.73M
Utile/perdita netta:
$-325.77M
Rapporto P/E:
-18.28
EPS:
-1.7725
Flusso di cassa netto:
$-332.79M
1 W Prestazione:
+1.69%
1M Prestazione:
-0.64%
6M Prestazione:
-7.30%
1 anno Prestazione:
-28.03%
Intervallo 1D:
$31.81
$33.39
Intervallo di 1 settimana:
$31.44
$33.39
Portata 52W:
$27.34
$47.79
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Nome
Legend Biotech Corp Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta LEGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
32.40 | 5.95B | 797.73M | -325.77M | -332.79M | -1.7725 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-10-08 | Iniziato | Redburn Atlantic | Buy |
| 2024-06-17 | Iniziato | Truist | Buy |
| 2024-05-24 | Reiterato | H.C. Wainwright | Buy |
| 2024-05-23 | Iniziato | Deutsche Bank | Buy |
| 2024-04-17 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2024-04-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Iniziato | Raymond James | Outperform |
| 2023-12-19 | Iniziato | Scotiabank | Sector Perform |
| 2023-11-06 | Iniziato | Goldman | Buy |
| 2023-05-25 | Iniziato | William Blair | Mkt Perform |
| 2023-05-22 | Iniziato | Daiwa Securities | Buy |
| 2023-03-29 | Iniziato | H.C. Wainwright | Buy |
| 2023-03-24 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-06 | Iniziato | UBS | Buy |
| 2022-11-02 | Iniziato | Evercore ISI | Outperform |
| 2022-11-01 | Iniziato | Cowen | Outperform |
| 2022-10-31 | Iniziato | Guggenheim | Neutral |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-03-15 | Iniziato | Barclays | Overweight |
| 2022-01-31 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-21 | Iniziato | Piper Sandler | Overweight |
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2020-07-01 | Iniziato | JP Morgan | Overweight |
| 2020-07-01 | Iniziato | Jefferies | Buy |
| 2020-06-30 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Legend Biotech Corp Adr Borsa (LEGN) Ultime notizie
Sumitomo Mitsui Trust Group Inc. Sells 11,157 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
OVERSEA CHINESE BANKING Corp Ltd Invests $723,000 in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Allianz Asset Management GmbH Takes $458,000 Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Nordea Investment Management AB - MarketBeat
TD Asset Management Inc Has $3.67 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth By Investing.com - Investing.com South Africa
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth - Investing.com India
Ameritas Advisory Services LLC Makes New $32,000 Investment in Arbor Realty Trust $ABR - Defense World
Free cash flow per share of Legend Biotech Corp. Sponsored ADR – MUN:9LB - TradingView
Ameritas Advisory Services LLC Acquires Shares of 501 JPMorgan Diversified Return International Equity ETF $JPIN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives $69.25 Average PT from Analysts - Defense World
Vontobel Holding Ltd. Has $368,000 Holdings in Duolingo, Inc. $DUOL - Defense World
Vontobel Holding Ltd. Sells 1,634 Shares of Wynn Resorts, Limited $WYNN - Defense World
Avery Dennison (NYSE:AVY) Receives “Hold (C-)” Rating from Weiss Ratings - Defense World
Pagaya Technologies (NASDAQ:PGY) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Vontobel Holding Ltd. Makes New Investment in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Krystal Biotech, Inc. $KRYS Stock Holdings Boosted by Vontobel Holding Ltd. - Defense World
Vontobel Holding Ltd. Cuts Stock Position in Waters Corporation $WAT - Defense World
Southern Copper Corporation $SCCO Shares Sold by Vontobel Holding Ltd. - Defense World
Vontobel Holding Ltd. Sells 10,000 Shares of Zeta Global Holdings Corp. $ZETA - Defense World
Bennett Associates Wealth Management Has $523,000 Holdings in JPMorgan Chase & Co. $JPM - Defense World
Analysts Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $69.25 - Defense World
US FDA adds label warning to J&J’s and Legend Biotech’s cancer therapy By Reuters - Investing.com
JPMorgan Chase & Co. Cuts Legend Biotech (NASDAQ:LEGN) Price Target to $76.00 - Defense World
Mirae Asset Global Investments Co. Ltd. Has $530,000 Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
US FDA adds boxed warning to J&J, Legend Biotech’s cancer therapy By Reuters - Investing.com
Legend Biotech (NASDAQ:LEGN) Research Coverage Started at Cantor Fitzgerald - Defense World
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Public Employees Retirement System of Ohio - Defense World
GAMMA Investing LLC Has $30,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Matthews International Capital Management LLC Has $45.89 Million Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Voya Investment Management LLC Takes Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Harbor Capital Advisors Inc. Grows Stock Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Rhumbline Advisers Buys 391 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Advisors Asset Management Inc. Has $673,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - MSN
Alliancebernstein L.P. Purchases 32,101 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech stock rating reiterated at Outperform by RBC Capital - Investing.com
Legend Biotech Corporation Sponsored ADR $LEGN Stake Decreased by Cinctive Capital Management LP - MarketBeat
Nomura Holdings Inc. Purchases New Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech at Morgan Stanley Conference: CARVYKTI’s Global Impact - Investing.com
Legend Biotech (NASDAQ:LEGN) Shares Up 5.4%Here's Why - MarketBeat
Legend Biotech Mulling 2nd Listing in HK, Singapore, or London: Wire - AASTOCKS.com
Northern Trust Corp Has $9.73 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Rexel (OTCMKTS:RXLSF) Stock Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Cantor Fitzgerald Expects Weaker Earnings for Legend Biotech - MarketBeat
Legend Biotech’s SWOT analysis: carvykti success drives stock potential amid challenges - Investing.com India
Legend Biotech Corp Adr Azioni (LEGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):